NIH Launches Human Trials for Groundbreaking Lassa Fever Vaccine
The Dawn of Dual-Purpose Vaccines: A Leap Forward in Preventive Health In a groundbreaking move spearheaded by the National Institutes of Health (NIH), human trials for LASSARAB, a dual-purpose vaccine against Lassa fever and rabies, have commenced. This development heralds a promising era in preventive health, illustrating innovative strategies in tackling multiple diseases simultaneously. With … Read more